Cross Country Healthcare to Discuss Q2 2024 Financial Results

Cross Country Healthcare, Inc. (Nasdaq: CCRN) has announced that they will be discussing their second quarter 2024 financial results on Wednesday, July 31, 2024, at 5:00 p.m. Eastern Time. The company intends to release its earnings press release after the market closes on the same day.

Cross Country Healthcare, Inc. is a market-leading, tech-enabled workforce solutions and advisory firm with 38 years of industry experience. The company aims to help clients tackle complex labor-related challenges and achieve high-quality outcomes while reducing complexity and improving visibility through data-driven insights. Diversity, equality, and inclusion are central to the organization's corporate social responsibility program.

The upcoming discussion of the second quarter 2024 financial results presents an opportunity to assess the company's performance during this period. Investors and stakeholders will be keen to analyze the changes in key financial metrics such as revenue, net income, and earnings per share compared to the previous quarter.

The webcast of the conference call will be accessible on the company's website, and a replay will be available for a limited time. This event will provide valuable insights into the company's financial standing and its strategic direction moving forward.

As the date approaches, market participants will be anticipating the release of the company's earnings press release to delve into the specific figures and assess the performance of Cross Country Healthcare, Inc. for the second quarter of 2024. Today the company's shares have moved 1.7% to a price of $13.81. For the full picture, make sure to review Cross Country Healthcare's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS